Year None202220212020201920182017 Jan 24 U.S. Food and Drug Administration Revises Emergency Use Authorization for REGEN-COV® (casirivimab and imdevimab) Antibody Cocktail due to Omicron Variant 220.7 KB
U.S. Food and Drug Administration Revises Emergency Use Authorization for REGEN-COV® (casirivimab and imdevimab) Antibody Cocktail due to Omicron Variant 220.7 KB